3D細胞培養足場市場の2030年までの予測： タイプ別、用途別、地域別の世界分析

Stratistics MRCによると、世界の3D細胞培養足場市場は予測期間中に17.0%のCAGRで成長する見込みです。

三次元（3D）細胞培養足場またはマトリックスの製造、販売、応用に関する世界の産業は、"3D細胞培養足場市場"として知られています。これらの足場は、三次元での細胞の発生、増殖、分化に好都合な環境を提供し、生体組織や臓器に見られる状況に酷似しています。この市場には、合成ポリマー、脱細胞化組織、ハイドロゲル、その他、これらの3D構造体の製造に使用される材料や技術が幅広く含まれています。

国立衛生研究所によると、2020年の各種バイオエンジニアリング技術への投資総額は5,646米ドルに達し、2019年の5,091米ドルから増加しました。米国保健資源サービス庁のウェブサイト「organdonor.gov」によると、2021年10月、2020年の全米臓器移植待機患者数は10万7,103人だっています。

再生医療と組織工学

移植用の機能的な組織や臓器の生産を促進する3D細胞培養スキャフォールドの機会は、再生医療や組織工学アプリケーションへの関心の高まりによってもたらされます。さらに、医薬品開発において、より信頼性の高いin vitroモデルに対する需要が高まっており、薬の有効性と安全性をテストするためのより優れた予測ツールを構築するチャンスがあります。

コスト、標準化、複雑性

足場材料や技術は多岐にわたるため、3D細胞培養足場を用いた研究のための標準化されたプロトコルを作成することは困難です。しかし、従来の2次元培養技術よりも高価であるため、3次元細胞培養足場や関連技術は、特に資源が限られている環境では、それほど広く使われていない可能性があります。

技術の進歩とがん研究

in vitro細胞モデルの精度と生理学的妥当性は、足場ベースのアプローチを含む3D細胞培養技術の継続的な開発によって向上しており、足場に対する需要が増加しています。さらに、がん研究や投薬試験において、足場を用いた3D細胞培養モデルは、より複雑でリアルな腫瘍モデルを可能にし、より優れた治療アプローチにつながります。

規制の壁

3D細胞培養用スキャフォールド事業は、特に薬物試験や安全性評価に利用される場合、規制によって遅延やコスト増が生じる可能性があります。特に医薬品開発や毒性試験において、3D細胞培養モデルの使用には複雑な規制が適用される可能性があります。これらの規則を遵守し、必要な承認を得るためには、多くのリソースと時間がかかる可能性があります。

COVID-19影響：

パンデミックは、世界の供給ラインの混乱により、3D細胞培養用スキャフォールドの製造に必要不可欠な材料やコンポーネントの入手に影響を与えました。その結果、製造業者は遅延と経費の増加を経験しました。パンデミック時の研究開発部門の予算制限は、経済の不確実性が原因であり、3D細胞培養用足場への投資に影響を与えた可能性があります。

予測期間中、合成ポリマーセグメントが最大となる見込み

予測期間中、合成ポリマーセグメントが最大のシェアを占めると予想されています。3次元細胞培養足場市場の重要な構成要素である合成ポリマー分野は、3次元細胞培養環境を開発するための特定の品質を持つ設計された材料を幅広く提供しています。さらに、個別化治療のための複雑な細胞培養条件を作り出すために、合成ポリマーはその汎用性と生体適合性から極めて重要です。合成ポリマーは、機能する組織や臓器の開発を促進することで、再生医療を進歩させるチャンスを提供します。

予測期間中にCAGRが最も高くなると予想されるのはバイオ医薬品分野です。

CAGRが最も高いと予想されるのはバイオ医薬品分野です。3D細胞培養スキャフォールドは、創薬・薬剤開発プロセスを加速させるためにバイオ医薬品企業によって使用されています。これらの足場は、生体内の状況をより正確に近似させ、医薬品候補のより正確な有効性と安全性の評価を可能にします。さらに、毒性、がん、標的医薬品の設計に関する研究のために、生理学的に正確な細胞モデルを作製する上で極めて重要です。3D細胞培養スキャフォールド市場は、バイオ医薬品企業が個々の患者の反応に基づいて医薬品をカスタマイズできるようにすることで、個別化医療の追求を支援しています。

最もシェアの高い地域

最もシェアが高いのはアジア太平洋地域です。3D細胞培養モデルに依存する精密医療と組織再生は、この地域が医療ツーリズムとハイテクヘルスケアサービスの中心地として発展するにつれて、ますます重要性を増しています。さらに、中国やインドのような国々の力強い経済成長によって、ヘルスケアやライフサイエンスへの投資が促進され、最先端の細胞培養技術に対する需要が高まっています。

CAGRが最も高い地域：

アジア太平洋地域は急成長が見込まれています。この地域では心血管系疾患が蔓延しているため、これらの疾患をよりよく理解し、治療法を生み出すために、血管生物学の研究と3D細胞培養足場の作製が進められています。さらに、アジア太平洋地域の製薬部門は、3D細胞培養モデルを使用して、心血管治療薬を試験し、それらが血管生物学にどのように影響するかを評価し、医薬品開発に役立てています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • お客様のご希望に沿った主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• アプリケーション分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の3D細胞培養足場市場：タイプ別

• ファイバ
• ハイドロゲル
• 脱細胞化足場
• 合成ポリマー
• その他のタイプ

第6章 世界の3D細胞培養足場市場：アプリケーション別

• バイオ医薬品
• 科学調査
• 血管生物学
• ヒト組織工学
• 創薬と開発
• バイオプリンティング
• その他の用途

第7章 世界の3D細胞培養足場市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第8章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第9章 企業プロファイル

• 3D Biotek
• Corning Incorporated
• Greiner Bio-One
• InSphero AG
• Lonza Group
• Merck KGaA
• N3d Bioscience
• Nanofiber Solutions
• Reprocell Incorporated
• Synthecon Incorporated
• TARA Biosystems
• Thermo Fisher Scientific

List of Tables

• Table 1 Global 3D Cell Culture Scaffold Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 4 Global 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 5 Global 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 6 Global 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 7 Global 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 8 Global 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 9 Global 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 10 Global 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 11 Global 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 12 Global 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 13 Global 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 14 Global 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 15 Global 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 16 North America 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 18 North America 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 19 North America 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 20 North America 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 21 North America 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 22 North America 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 23 North America 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 24 North America 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 25 North America 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 26 North America 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 27 North America 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 28 North America 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 29 North America 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 30 North America 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 31 Europe 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 33 Europe 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 34 Europe 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 35 Europe 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 36 Europe 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 37 Europe 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 38 Europe 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 39 Europe 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 40 Europe 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 41 Europe 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 42 Europe 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 43 Europe 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 44 Europe 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 45 Europe 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 46 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 48 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 49 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 50 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 51 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 52 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 53 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 54 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 55 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 56 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 57 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 58 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 59 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 60 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 61 South America 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 62 South America 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 63 South America 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 64 South America 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 65 South America 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 66 South America 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 67 South America 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 68 South America 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 69 South America 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 70 South America 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 71 South America 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 72 South America 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 73 South America 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 74 South America 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 75 South America 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 76 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 77 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 78 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 79 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 80 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 81 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 82 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 83 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 84 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 85 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 86 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 87 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 88 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 89 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 90 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)

According to Stratistics MRC, the Global 3D Cell Culture Scaffold Market is expected to grow at a CAGR of 17.0% during the forecast period. The global industry for the manufacture, sale, and application of three-dimensional (3D) cell culture scaffolds or matrices is known as the "3D Cell Culture Scaffold Market." These scaffolds offer an environment that is favorable to cell development, proliferation, and differentiation in three dimensions and closely resembles the circumstances found in living tissues and organs. The market includes a wide range of synthetic polymers, decellularized tissues, hydrogels, and other materials and technologies that are used to produce these 3D structures.

According to the National Institute of Health, in 2020, the total investment in various bio engineering technologies amounted to USD 5,646, an increase from USD 5,091 in 2019. According to the organdonor.gov website of the United States Health Resources and Services Administration, in October 2021, 107,103 patients were on the national organ transplant waiting list in the year 2020.

Market Dynamics:

Driver:

Regenerative medicine and tissue engineering

Opportunities for 3D cell culture scaffolds to promote the production of functional tissues and organs for transplantation are offered by the growing interest in regenerative medicine and tissue engineering applications. Additionally, the market acquires from the growing demand for more reliable in vitro models in drug development, providing the chance to build better prediction tools for testing medication efficacy and safety.

Restraint:

Cost, standardization and complexity

Due to the wide range of scaffold materials and technologies available, creating standardized protocols for 3D cell culture scaffold-based research can be difficult. However, they can be more expensive than conventional 2D culture techniques, 3D cell culture scaffolds and related technologies may not be as widely used, especially in environments with limited resources.

Opportunity:

Technology advancements and cancer research

The accuracy and physiological relevance of in vitro cell models are being improved by ongoing developments in 3D cell culture techniques, including scaffold-based approaches, which are increasing the demand for scaffolds. Additionally, for cancer research and medication testing, 3D cell culture models using scaffolds allow for more complicated and realistic tumor models, which leads to better therapeutic approaches.

Threat:

Regulatory barriers

Regulations can cause delays and higher costs in the 3D cell culture scaffold business, particularly when utilized for drug testing and safety evaluations. Complex regulatory regulations may apply to the use of 3D cell culture models, particularly in drug development and toxicity testing. It can take a lot of resources and time to comply with these rules and get the required approvals.

COVID-19 Impact:

The pandemic affected the availability of essential materials and components needed to produce 3D cell culture scaffolds by disrupting global supply lines. Manufacturers experienced delays and higher expenses as a result. Budget restrictions in the research and development divisions during the pandemic were caused by economic uncertainty, which might have had an impact on investments in 3D cell culture scaffolds.

The synthetic polymers segment is expected to be the largest during the forecast period

Synthetic Polymers segment is expected to hold the largest share over the forecast period. A crucial component of the market for 3D cell culture scaffolds, the synthetic polymer sector provides an extensive range of designed materials with specific qualities for developing three-dimensional cell culture settings. Additionally, in order to create complex cell culture conditions for personalized treatment, synthetic polymers are crucial because of their versatility and biocompatibility. They provide the chance for advancements in regenerative medicine by facilitating the development of functioning tissues and organs.

The biopharmaceutical segment is expected to have the highest CAGR during the forecast period

Biopharmaceutical segment is expected to have the highest CAGR. 3D cell culture scaffolds are used by biopharmaceutical businesses to accelerate the drug discovery and development process. These scaffolds offer a more exact approximation of in vivo circumstances, enabling more accurate efficacy and safety assessments of drug candidates. Additionally, they are crucial in the production of physiologically accurate cell models for inquiries on toxicity, cancer, and the design of targeted medicines. The market for 3D cell culture scaffolds aids biopharmaceutical companies in the pursuit of personalized medicine by enabling them to customize medicines based on individual patient responses.

Region with largest share:

The largest share was held by the Asia-Pacific area. Precision medicine and tissue regeneration, which rely on 3D cell culture models, are becoming more and more important as the area develops as a center for medical tourism and high-tech healthcare services. Additionally, investments in healthcare and life sciences are being fueled by the robust economic growth of nations like China and India, which is raising the demand for cutting-edge cell culture technologies.

Region with highest CAGR:

Asia Pacific region is expected to grow rapidly. The prevalence of cardiovascular disorders in the area has prompted an examination of vascular biology and the creation of 3D cell culture scaffold in an effort to better understand these illnesses and create therapeutic remedies. Moreover, the Asia Pacific region's pharmaceutical sector uses 3D cell culture models to test cardiovascular medications and assess how they affect vascular biology, which helps in drug development.

Key players in the market:

Some of the key players in 3D Cell Culture Scaffold Market include: 3D Biotek, Corning Incorporated, Greiner Bio-One, InSphero AG, Lonza Group, Merck KGaA, N3d Bioscience, Nanofiber Solutions, Reprocell Incorporated, Synthecon Incorporated, TARA Biosystems and Thermo Fisher Scientific.

Key Developments:

In October 2023, Thermo Fisher expands US manufacturing plant to support biologics. The US-based biotechnology and medical equipment company has added multiple biologic manufacturing facilities to accommodate a growing demand for these therapies.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.

Types Covered:

• Fiber
• Hydrogel
• Decellularized Scaffolds
• Synthetic Polymers
• Other Types

Applications Covered:

• Biopharmaceutical
• Scientific Research
• Vascular Biology
• Tissue Engineering
• Drug Discovery and Development
• Bioprinting
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options::

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global 3D Cell Culture Scaffold Market, By Type

• 5.1 Introduction
• 5.2 Fiber
• 5.3 Hydrogel
• 5.4 Decellularized Scaffolds
• 5.5 Synthetic Polymers
• 5.6 Other Types

6 Global 3D Cell Culture Scaffold Market, By Application

• 6.1 Introduction
• 6.2 Biopharmaceutical
• 6.3 Scientific Research
• 6.4 Vascular Biology
• 6.5 Tissue Engineering
• 6.6 Drug Discovery and Development
• 6.7 Bioprinting
• 6.8 Other Applications

7 Global 3D Cell Culture Scaffold Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 3D Biotek
• 9.2 Corning Incorporated
• 9.3 Greiner Bio-One
• 9.4 InSphero AG
• 9.5 Lonza Group
• 9.6 Merck KGaA
• 9.7 N3d Bioscience
• 9.8 Nanofiber Solutions
• 9.9 Reprocell Incorporated
• 9.10 Synthecon Incorporated
• 9.11 TARA Biosystems
• 9.12 Thermo Fisher Scientific